Neuropace Share Price

Neuropace Share Price

NASDAQ: NPCE | Micro Cap | Healthcare
$7.97
-$0.14 (-1.73%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Neuropace Stock Performance

Open
$8.23
Prev. Close
$8.11
Circuit Range
N/A
Day Range
$7.84 - $8.28
Year Range
$5.47 - $19.57
Volume
39,504
Average Traded
$7.99

Neuropace Share Price Today

As of 21 November 2026, Neuropace, Inc.'s share price is $7.97. The stock opened at $8.23, compared to its previous close of $8.11. During today's trading session, Neuropace, Inc.'s share price traded between $7.84 and $8.28, with an average price of $8.06. Over the past 52 weeks, the stock has recorded a high of $19.57 and a low of $5.47. In terms of performance, Neuropace, Inc.'s share price has declined by 51.58% over the last six months and is down 51.27% on a year-on-year basis.

Neuropace Share Price Chart

Line chart of the Neuropace price trend over the selected period. The price fell overall, ranging from 7.90 to 8.28, ending at 7.97.
$7.84$8.28
L
Show Current Price
H

Neuropace Stock Fundamentals & Key Indicators

Market Cap
$260.80M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.55
Revenue (TTM)
$99.99B
Return On Equity (TTM)
-164.60%
Profit Margin
-21.47%
Debt to Equity
5.15
Quarterly Earnings Growth YoY
-20.88%

Neuropace Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$26.59$22.07$22.83$23.10
Net Profit-$2.73-$6.69-$6.20-$3.30
Net Profit Margin-10.27%-30.31%-27.16%-14.29%
Income ChangeN/A-145.05%7.32%46.77%

Neuropace Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$45.52$65.42$79.91$99.99
Net Profit-$47.08-$32.96-$27.14-$21.47
Net Profit Margin-103.43%-50.38%-33.96%-21.47%
Income ChangeN/A29.99%17.66%20.89%

Neuropace Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets11.4913.3114.9316.39
Current Assets94.0781.3492.7297.71
Total Assets105.5794.65107.65114.11
Non Current Liabilities69.3271.4870.7768.35
Current Liabilities17.2215.1616.2310.98
Total Liabilities86.5386.6387.079.33
Shareholders' Equity19.038.0120.6534.78

Neuropace Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-11.01-17.95-19.7-36.87
Investing-0.338.9923.0323.8
Financing19.64.338.130.49

About Neuropace

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Neuropace Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$12.42
$7.99
-34.93%
Oct 2026
$13.55
$12.28
-10.76%
Sep 2026
$14.52
$13.76
-2.58%
Aug 2026
$13.22
$14.13
+10.05%
Jul 2026
$16.11
$12.84
-19.28%
Jun 2026
$16.25
$15.90
-3.40%
May 2026
$16.92
$16.46
-2.43%
Apr 2026
$13.66
$16.87
+28.39%
Mar 2026
$14.28
$13.14
-9.57%
Feb 2026
$15.38
$14.53
-3.97%
Jan 2026
$15.18
$15.13
-2.13%
Dec 2025
$16.33
$15.46
-5.47%

Neuropace Share Price FAQs